Show simple item record

dc.contributor.advisorRascati, Karen L.en
dc.contributor.advisorWilson, James P.en
dc.creatorTiller, Kevin Wadeen
dc.date.accessioned2008-08-28T21:53:45Zen
dc.date.available2008-08-28T21:53:45Zen
dc.date.issued2004en
dc.identifierb59058742en
dc.identifier.urihttp://hdl.handle.net/2152/1271en
dc.descriptiontexten
dc.format.mediumelectronicen
dc.language.isoengen
dc.rightsCopyright is held by the author. Presentation of this material on the Libraries' web site by University Libraries, The University of Texas at Austin was made possible under a limited license grant from the author who has retained all copyrights in the works.en
dc.subject.lcshOsteoporosis in women--Treatment--Cost effectivenessen
dc.subject.lcshOsteoporosis in women--Prevention--Cost effectivenessen
dc.subject.lcshOsteoporosis in women--Treatmenten
dc.subject.lcshOsteoporosis in women--Risk factorsen
dc.subject.lcshOsteoporosis in women--Epidemiologyen
dc.subject.lcshOsteoporosis in women--Hormone therapy--Cost effectivenessen
dc.subject.lcshOsteoporosis in women--Hormone therapyen
dc.titleAlendronate and hormone replacement therapy in the prevention of osteoporotic fracture: a pharmacoeconomic analysis employing a net-benefit regression method of cost-effectivenessen
dc.description.departmentPharmacyen
dc.identifier.oclc57663420en
dc.identifier.proqst3143479en
dc.type.genreThesisen
thesis.degree.departmentPharmacyen
thesis.degree.disciplinePharmacyen
thesis.degree.grantorThe University of Texas at Austinen
thesis.degree.levelDoctoralen
thesis.degree.nameDoctor of Philosophyen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record